Paolo Fornengo

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Hospital Admissions for Hypertensive Crisis in the Emergency Departments: A Large Multicenter Italian Study

Giuliano Pinna, Claudio Pascale, Paolo Fornengo et al. · PLoS ONE · 2014 · 142 citations · Full text

Medicine, Emergency Medicine, Crisis Management +8

Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients

Francesco Panero, Giulia Novelli, Chiara Zucco et al. · Diabetes Care · 2008 · 136 citations · Full text

Medicine, Clinical Sciences, Endocrinology +15

Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: A population-based study

Francesco Panero, Gabriella Gruden, Massimo Perotto et al. · Atherosclerosis · 2011 · 88 citations

Medicine, Internal Medicine, Diabetology +7

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11